Methods of targeting PTEN mutant diseases and compositions therefor
US9402828B2 · kind B2 · utility
13Cited by
1References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 9, 2015 |
| Grant date | Aug 2, 2016 |
| Priority date | — |
| Expiry date | Jan 9, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods and compositions for treating a patient with cancer wherein the cancer is characterized by a PTEN gene mutation and/or a PI3K gene mutation. In particular embodiments, the methods comprise administering to the patient a composition comprising a therapeutically effective amount of a PLK4 antagonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.